Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

https://oncologypro.esmo.org/Meeting-Resour...DL1-blockade-effect-in-a-sarcoma-mouse-model

) the application of an appropriate comprehensive strategy for the deep delineation of mechanisms underlying resistance/sensitivity to a drug.

Methods

Using a syngeneic sarcoma mouse model, treated ... Comprehensive assessment of anti-tumour PDL1 blockade effect in a sarcoma mouse model ... Basic Science 0 None 0 0 0 0 1542927600 Sarcoma 0 Here below, you will find a list of all the latest content published on this website on the topic of Sarcoma. The content is published

Date: 12 Dec 2019
Presenter: Imane Nafia
Resources: Abstract
Topics: Basic Science, Sarcoma

https://oncologypro.esmo.org/Meeting-Resour...ts-potential-effectiveness-for-immunotherapy

dermal sarcoma (PDS) is a rare cutaneous tumour with local recurrences and distant metastases occurring up to 20% of the cases. With only limited treatment options in advanced stages, there is a strong ... Profiling the tumour immune microenvironment in pleomorphic dermal sarcomas suggests its potential effectiveness for immunotherapy ... order. Find out more about our content categorisation . None 0 0 0 0 1167606000 Sarcoma 0 Here below, you will find a list of all the latest content published on this website on the topic of Sarcoma

Date: 12 Dec 2019
Presenter: Ka-won Noh
Resources: Abstract
Topics: Immunotherapy, Sarcoma

https://oncologypro.esmo.org/Meeting-Resour...-immunotherapy-TILs-and-personalized-vaccine

the successful treatment for the patients with recurrent Gastrointestinal Stromal Tumors (GIST) with adoptive cellular immunotherapy and personalized vaccine.

Methods

A total of 8 patients (aged from ... GIST 0 Here below, you will find a list of all the latest content published on this website on the topic of GIST. The content is published in chronological order. Find out more about our content

Date: 12 Dec 2019
Presenter: Alexandre Tavartkiladze
Resources: Abstract
Topics: GIST, Personalised/Precision Medicine, Immunotherapy

https://oncologypro.esmo.org/Meeting-Resour...te-derived-dendritic-cell-anticancer-vaccine

Background

Refractory and relapsing sarcoma and high-risk neuroblastoma show poor prognoses. Monocyte-derived dendritic cell anticancer vaccine could extend the treatment modalities

Date: 12 Dec 2019
Presenter: Eva Hlavackova
Resources: Abstract
Topic: Tumour Immunology

https://oncologypro.esmo.org/Meeting-Resour...reated-by-dendritic-cell-based-immunotherapy

sarcomas disease were treated with DCs pulsed with self-tumor antigens. DC ITx was administered intradermally in 2-4 week intervals. Peripheral blood was collected at baseline, after 5th, 9th and 13th dose ... Evaluation of immune response in young patients with sarcoma treated by dendritic cell-based immunotherapy ... order. Find out more about our content categorisation . None 0 0 0 0 1167606000 Sarcoma 0 Here below, you will find a list of all the latest content published on this website on the topic of Sarcoma

Date: 12 Dec 2019
Presenter: Lenka Fedorova
Resources: Abstract
Topics: Immunotherapy, Sarcoma

https://oncologypro.esmo.org/Meeting-Resour...noma-sRCC-patients-in-an-Asian-cancer-centre

Background

Renal cell carcinoma with sarcomatoid de-differentiation (sRCC) is a highly aggressive form RCC with trials reporting a poor median OS of 5 to 12 months. Recent genomics ... An observational retrospective real-world study of sarcomatoid renal cell carcinoma (sRCC) patients in an Asian cancer centre

Date: 23 Nov 2019
Presenter: Ravindran Kanesvaran
Resources: Abstract
Topic: Renal Cell Cancer

https://oncologypro.esmo.org/Meeting-Resour...ed-renal-cell-carcinoma-and-its-implications

>PNET3 (1.2%)Sarcomatoid5 (2.1%)Unclassified5 (2.1%)Average tumor size-RTS5.22 (SD 2.15)

Date: 23 Nov 2019
Presenter: Shanky Singh
Resources: Abstract
Topic: Renal Cell Cancer

https://oncologypro.esmo.org/Meeting-Resour...cell-lung-cancer-NSCLC-patients-in-Hong-Kong

complete exon sequencing of EGFR. We identified cases with a diagnosis of “lung cancer” and excluded pure squamous, small cell, neuroendocrine and sarcomatoid histology. Uncommon EGFR alterations, defined

Date: 23 Nov 2019
Presenter: Oscar Siu Hong Chan
Resources: Abstract
Topic: Non-Small Cell Lung Cancer

https://oncologypro.esmo.org/Meeting-Resour...ogical-characteristics-and-treatment-outcome

Background

Uterine sarcomas (US) are a rare, heterogeneous group of malignancies that have rapid progressive clinical course and poor prognosis. We are reporting a retrospective review ... Uterine sarcomas in Qatar: Clinico-pathological characteristics and treatment outcome ... Soft Tissue Sarcomas 0 Here below, you will find a list of all the latest content published on this website on the topic of Soft Tissue Sarcomas. The content is published in chronological order

Date: 23 Nov 2019
Presenter: Ashraf Fadlelseid
Resources: Abstract
Topic: Soft Tissue Sarcomas

https://oncologypro.esmo.org/Meeting-Resour...d-tumours-in-Hong-Kong-A-report-of-253-cases

included sarcomas (n = 88, 35%), NSCLC (n = 61, 24%), glioma (n = 42, 17%), melanoma (n = 7, 3%) and others (n = 55, 21%). Median turn-around time from consent to availability of report: 24 days (range: 3

Date: 23 Nov 2019
Presenter: Herbert Loong
Resources: Abstract
Topic: Personalised/Precision Medicine